Global Presence Helios Global Group operates across multiple markets including the UK and the US, with a significant client base in the pharmaceutical and biotechnology sectors, indicating opportunities for tailored international communication solutions and regional market expansion support.

Recent Acquisition Growth The recent acquisition of Cogentia and the purchase by Telemos Capital highlight the company's expansion strategy and investment appeal, suggesting potential for customized integration services, growth consulting, and scalable technology platforms.

Financial Potential With annual revenues estimated between 10 and 25 million dollars and a workforce of up to 500 employees, Helios offers a promising market for software solutions, consultancy, and services aimed at mid-sized pharmaceutical communications firms.

Industry Focus Specializing in healthcare communications and market access, Helios is a prime target for sales of medical content management systems, digital engagement tools, and analytics platforms that enhance medical education and behavioural change strategies within healthcare.

Technology Stack The company's use of cloud services, CDN, and social sharing platforms indicates openness to advanced cloud-based, security-focused, and social media integration solutions to optimize their digital communication channels and client engagement strategies.